# Akari Therapeutics Plc: Form 8-K, filed Mar 17, 2026

- Company: [Akari Therapeutics Plc](/companies/aktx.md) (CIK 1541157)
- Form: 8-K
- Filed: 2026-03-17
- Accepted by EDGAR: Mar 17, 2026, 17:07 ET
- Period: 2026-03-17
- Accession: 0001493152-26-010602
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1541157/000149315226010602/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1541157/000149315226010602/

## Items reported

- Item 3.03: Change to security holders’ rights
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1541157/000149315226010602/form8-k.htm

Filed Mar 17, 2026.
Source: SEC EDGAR, the filing index for accession 0001493152-26-010602. Last ingested by Listed: Oct 30, 2026, 17:09 ET. No prices; not investment advice.